Altimmune is a clinical stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. We strategically employ our two distinct and complementary immune platform technologies to create innovative candidates for important diseases.

Biotechnology

Altimmune

Vipin K. Garg

Tony Blandin

Karen Smith

Jay Yang

Anthony Blandin

Raymond Jordt

Richard Eisenstadt

M. Scott Harris

Scot Roberts

Ori Solomon

Bertrand Georges

Clinical and Medical Affairs

Directors Team

Leadership Team

Finance and Accounting Team

Corporate Development and Strategy

Regulatory and Compliance Team

Biostatistics and Data Management Team

Research and Development

Teams at Altimmune